Tuesday, March 14, 2017

APRI On Track, Stellar Bio Shines, FDA Nod For NVS, Study Results Heat Up HTBX

Apricus Biosciences Inc. expects to resubmit the NDA for Vitaros in the third quarter of 2017.

from RTT - Biotech http://ift.tt/2no7huC
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)